The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy and safety of a selective PARP1 inhibitor ACE-86225106 in patients with advanced solid tumors: Preliminary results from a first-in-human phase 1/2 study.
 
Jiongjie Chen
Employment - Acerand Therapeutics
Leadership - Acerand Therapeutics
 
Jian Zhang
No Relationships to Disclose
 
Zhanhong Chen
No Relationships to Disclose
 
Yu Chen
No Relationships to Disclose